Castrate Resistant Prostate Cancer Is Estimated To Witness High...

agregó una foto Health

2024-01-04 09:58:42 -

Castrate Resistant Prostate Cancer Is Estimated To Witness High Growth

Prostate cancer is one of the most common cancers diagnosed among men worldwide. Castrate resistant prostate cancer (CRPC) refers to prostate cancer that continues to progress even after androgen deprivation therapy through surgical or chemical castration. Products like chemotherapy drugs, hormone therapy drugs, immunotherapy, and radiation therapy are used for treating CRPC. The increasing...

0 Commentarios 0 Acciones 2K Views 0 Vista previa